JPRN-jRCT2080222564未知3 期
ong-Term Study of CN-801 - Open-label study in patients with excessive daytime sleepiness associated with idiopathic hypersomnia
适应症
试验速览
- 阶段
- 3 期
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 16age old 至 <= 64age old（—）
- 性别
- All
入选标准
- •Patients diagnosed with idiopathic hypersomnia based on the International Classification of Sleep Disorders, second edition (ICSD-2) and who have completed the preceding double-blind comparative study
排除标准
- •Patients with narcolepsy, restless legs syndrome, periodic limb movement disorder, or sleep apnea syndrome
- •Patients working irregular shifts or night shifts
- •Patients with chronic sleep deprivation or patients with extremely irregular bed times
研究者
相似试验
未知
3 期
Phase 3 Clinical Study of CN-801 in patients with idiopathic hypersomniaIdiopathic hypersomniaJPRN-jRCT2080222488Alfresa Pharma Corporation
进行中（未招募）
1 期
A treatment study of ACH-0144471 in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) Who Have poor Response to Eculizumab MonotherapyEUCTR2016-003526-16-GBAlexion Pharmaceuticals Inc.14
撤回
2 期
An open-label study of combination therapy of CNSA-001 with levodopa in patients with Parkinson's Disease for the treatment of motor and non-motor symptoms of Parkinson's Disease.Neurological - Parkinson's diseaseParkinson's DiseaseACTRN12620000671965Censa Pharmaceuticals Australia Pty Ltd6
招募中
2 期
Study of NM8074 in Adult PNH PatientsCTRI/2023/02/049717ovelMed Therapeutics
尚未招募
2 期
Treatment of Chronic aHUS with NM8074CTRI/2023/10/058601ovelMed Therapeutics